Literature DB >> 27380871

Transcatheter Arterial Embolization with a Mixture of Absolute Ethanol and Iodized Oil for Poorly Visualized Endophytic Renal Masses Prior to CT-Guided Percutaneous Cryoablation.

Kenkichi Michimoto1, Kanichiro Shimizu2, Yoshihiko Kameoka2, Shunichi Sadaoka2, Jun Miki3, Koichi Kishimoto3.   

Abstract

PURPOSE: To retrospectively evaluate the feasibility of transcatheter arterial embolization (TAE) using a mixture of absolute ethanol and iodized oil to improve localization of endophytic renal masses on unenhanced computed tomography (CT) prior to CT-guided percutaneous cryoablation (PCA).
MATERIALS AND METHODS: Our institutional review board approved this retrospective study. From September 2011 to June 2015, 17 patients (mean age, 66.8 years) with stage T1a endophytic renal masses (mean diameter, 26.5 mm) underwent TAE using a mixture of absolute ethanol and iodized oil to improve visualization of small and endophytic renal masses on unenhanced CT prior to CT-guided PCA. TAE was considered successful that accumulated iodized oil depicted whole of the tumor edge on CT. PCA was considered successful when the iceball covered the entire tumor with over a 5 mm margin. Oncological and renal functional outcomes and complications were also evaluated.
RESULTS: TAE was successfully performed in 16 of 17 endophytic tumors. The 16 tumors were performed under CT-guided PCA with their distinct visualization of localization and safe ablated margin. During the mean follow-up period of 15.4 ± 5.1 months, one patient developed local recurrence. Estimated glomerular filtration rate declined by 8 % with statistical significance (P = 0.01). There was no procedure-related significant complication.
CONCLUSION: TAE using a mixture of absolute ethanol and iodized oil to improve visualization of endophytic renal masses facilitated tumor localization on unenhanced CT, permitting depiction of the tumor edge as well as a safe margin for ablation during CT-guided PCA, with an acceptable decline in renal function.

Entities:  

Keywords:  CT guidance; Iodized oil; Percutaneous cryoablation; Transcatheter arterial embolization

Mesh:

Substances:

Year:  2016        PMID: 27380871     DOI: 10.1007/s00270-016-1414-2

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

1.  Percutaneous cryoablation for clinical T3a renal cell carcinoma (< 7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan.

Authors:  Mayu Uka; Toshihiro Iguchi; Nanako Okawa; Yusuke Matsui; Koji Tomita; Noriyuki Umakoshi; Kazuaki Munetomo; Hideo Gobara; Motoo Araki; Takao Hiraki
Journal:  Jpn J Radiol       Date:  2022-06-21       Impact factor: 2.374

2.  Transarterial embolization of renal cell carcinoma as an adjunctive therapy prior to cryoablation: a propensity score matching analysis.

Authors:  Andrew J Gunn; Benjamin J Mullenbach; May M Poundstone; Jennifer B Gordetsky; Edgar S Underwood; Soroush Rais-Bahrami
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

Review 3.  [What can/should be treated in kidney tumors and when].

Authors:  C M Sommer; D F Vollherbst; G M Richter; H U Kauczor; P L Pereira
Journal:  Radiologe       Date:  2017-02       Impact factor: 0.635

4.  Percutaneous cryoablation for stage T1b renal cell carcinoma in a patient with horseshoe kidney.

Authors:  Kanichiro Shimizu; Hisayo Furube; Kenkichi Michimoto; Takafumi Yanagisawa; Jun Miki; Koichi Kishimoto; Shunichi Sadaoka
Journal:  Radiol Case Rep       Date:  2018-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.